Global Intellectual Property Specialists

Strategic global thinking for the pharmaceutical and biopharmaceutical industries

Our Capabilities

We use our global experience to support life sciences clients from early R&D to commercial launch, and beyond.

Explore our BioBlast®

View our interactive biosimilar news updates, collating tailored reports by brand, INN, originator/biosimilar applicant, litigation, region, or date.

Our People

Our lawyers and attorneys have science backgrounds, were trained at top tier firms, and most have experience in-house at multinational giants.

Award-winning IP services

Ranked internationally and domestically, our pharmaceutical, biopharmaceutical and life sciences focussed lawyers and attorneys are recognised as being among the best IP practitioners in the world.

Our Capabilities

Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys, to the pharmaceutical, biopharmaceutical and life sciences industries.

We coordinate and execute local and multi-jurisdictional IP litigation strategies, provide IP/legal support for regional and global business development activities and licensing deals, and prosecute patent and trade mark applications around the world.

Patent: Legal and Attorney Services

Trade Mark: Legal and Attorney Services

Commercial IP Services

Regulatory Affairs Services

View our Capabilities

Since its establishment in 2017 boutique Pearce IP has dominated in the area of pharmaceutical patents. Thanks to its deep bench of talented professionals, any life sciences brief is dispatched with alacrity and poise.

IAM Patent 1000, 2024

IP SPECIALISTS LAWYERS – PATENT ATTORNEYS – TRADE MARK ATTORNEYS

Our Leaders

Naomi Pearce

CEO, Executive Lawyer (AU, NZ), Patent & Trade Mark Attorney (AU, NZ)

Adele Chadwick

Executive, Deputy CEO & Head of Talent

Paul Johns

Executive, Lawyer (Head of Litigation - New Zealand)

Chris Vindurampulle PhD

Executive, Patent & Trade Mark Attorney (Head of Patent Prosecution)

Kimberley Evans

Executive, Lawyer & Trade Mark Attorney (Head of Trade Marks)

Chris Coates (Maj Ret)

Executive, Finance

Helen Macpherson

Executive, Lawyer (Head of Litigation - Australia)

PEARCE IP BLOG

Read our latest updates & insights

A Matter of Taste: IPONZ Decision Serves Up Important Reminders on Patent Practice

by Naomi Pearce, Julie Ballance, Nathan Kan | Jan 15, 2025

In October 2024, the Intellectual Property Office of New Zealand (IPONZ) issued a decision concerning a patent application by Suntory Holdings Limited (Suntory) relating to the enhancement of sweetness in beverages using specific combinations of high-intensity sweeteners and sodium, while maintaining

Missing the Boat: NZ Court of Appeal Finds Delayed Patent Claims an Abuse of Process

by Naomi Pearce, Paul Johns, Nathan Kan | Jan 14, 2025

The New Zealand Court of Appeal has handed down its second appeal decision in the long-running dispute between Sealegs International Limited and Anura Limited (formerly Orion Marine Limited) and

Persistence Doesn’t Pay: Federal Court Calls Time on Decade-Long Patent Amendment Battle

by Naomi Pearce, Helen Macpherson, Nathan Kan | Jan 10, 2025

In a comprehensive Federal Court judgment, Justice Perram has ruled that pharmaceutical formulations can constitute a “pharmaceutical substance per se” under the Patents Act 1990 (Cth), dismissing Cipla’s